HOME >> MEDICINE >> NEWS
Predictors of undergoing joint replacement surgery among patients with severe osteoarthritis

A progressive, destructive joint disease, osteoarthritis (OA) is a major cause of disability worldwide. Total joint arthroplasty (TJA) is a highly successful and cost-effective procedure for managing OA of the hip and knee. Despite this, analyses of hospital records show variations in the rates of TJA by region, gender, race, and socioeconomic status. While these studies tell us about who is undergoing hip and knee replacement surgery, what's missing is why--a comprehensive, rigorous examination of the predisposing factors affecting TJA rates.

Why do some arthritis sufferers agree to undergo TJA and others resist it? To examine the predictors of time to a first TJA, a team of Canadian researchers, affiliated with the University of Toronto and other research institutes, conducted a population-based study of 2,128 individuals ages 55 and over with disabling OA of the hip and/or knee. Their findings, featured in the October 2006 issue of Arthritis & Rheumatism (http://www.interscience.wiley.com/journal/arthritis), support the need for community-based education about arthritis treatments, including hip and knee replacement surgery.

This groundbreaking study focused on two regions of Ontario--one rural with high rates of TJA and one urban with low rates. It started in 1999 with an established sample of older citizens--1,158 from the country; 970 from the city--with severe hip and/or knee OA and no prior joint replacement. Researchers devoted 7 years to follow up, consisting of annual surveys and check-ups on disease progression, linked with hospital databases to determine whether patients had undergone hip or knee replacement surgery.

Among the study population, 73 percent were women, 96 percent were white, 31 percent were living alone, independently, and nearly 68 percent had a high school education or higher. At baseline,
'"/>

Contact: Amy Molnar
amolnar@wiley.com
John Wiley & Sons, Inc.
28-Sep-2006


Page: 1 2 3

Related medicine news :

1. Medication does not appear to offer benefit for certain heart attack patients undergoing PCI
2. Should patients undergoing surgery get ASA?
3. Medication reduces risk of adverse events for patients with acute coronary syndromes undergoing PCI
4. Women with endometriosis undergoing IVF benefit from treatment with GnRH agonists
5. Distant prayer does not improve clinical outcome for patients undergoing coronary procedures
6. Patients may want to skip that cup of coffee before undergoing PET/CT scans
7. New methods offer alternatives for patients undergoing obesity surgery
8. Vicente Fox Center and RAND launch joint program to find policies to combat poverty
9. Experimental gene therapy abolishes arthritis pain and lessens joint damage
10. Slick and springy: Brown research reveals proteins role in joints
11. Key study offers hope to patients with lung and joint disease

Post Your Comments:
(Date:9/1/2015)... ... September 01, 2015 , ... With former IBMers among its founding ... since its inception more than 35 years ago. A pilot program begun by the ... - and, not just those intent on pursuing careers in these fields. The program ...
(Date:9/1/2015)... ... September 01, 2015 , ... Royal River Natural Foods, a locally-owned independent natural ... women for 19 years and found that, among those who had a stroke, people ... report is part of the September 2015 issue of “Natural Insights for Well Being,” ...
(Date:9/1/2015)... Boston, MA (PRWEB) , ... September 01, 2015 , ... ... the little-known and incurable disease, facioscapulohumeral muscular dystrophy (FSHD), will be the beneficiary of ... has the same mission – to raise awareness of the FSH Society and further ...
(Date:9/1/2015)... , ... September 01, 2015 , ... SC&H Group, a ... which includes being named a “Best of the Best” firm in the U.S., as ... named the “Best of the Best” in the U.S., selected exclusively on performance in ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... ... the 2015-2016 Distinguished Nurse Scholar-in Residence at the Institute of Medicine (IOM) of ... of Biomedical Informatics at Columbia University School of Nursing. A member of the ...
Breaking Medicine News(10 mins):Health News:Inmar Announces Program to Fuel Student Passion for STEM – with an Unconventional Twist 2Health News:New Study Finds Multivitamins Extend Life After Stroke, Retailer Reports 2Health News:FSH Society Beneficiary of Variety of Fall Fundraising Events 2Health News:FSH Society Beneficiary of Variety of Fall Fundraising Events 3Health News:SC&H Group Receives Multiple Honors from INSIDE Public Accounting 2Health News:Columbia Nursing’s Suzanne Bakken Named Distinguished Institute of Medicine Nurse Scholar-in-Residence 2
(Date:9/1/2015)... , Sept. 1, 2015  Results from an interim ... demonstrate that 5g of idarucizumab enabled emergency surgery ... patients treated with dabigatran (Pradaxa ® dabigatran ... anticoagulant effect of dabigatran enabled patients to be ... time of 1.7 hours between administration of idarucizumab ...
(Date:9/1/2015)... 1, 2015   Ivenix Inc. , a ... system, closed on a $42M round of equity ... Cardinal Partners, CICA, Inc., Easterly Capital, Fidelity Biosciences, ... round. This financing will support the company,s efforts ... Partners LLC acted as the exclusive placement agent ...
(Date:9/1/2015)... 2015 Within just two years after reaching ... rapidly reached 3,000 employees worldwide. This increase is ... injectable drug delivery market and SHL,s effective commitment, ... in the design and manufacturing of auto injectors ... manufacturing capabilities, a lean supply chain, strong partnerships, ...
Breaking Medicine Technology:New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 2New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 3New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 4New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 5New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 6New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 7New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 8New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 9Ivenix Inc. Secures $42 Million in Funding 2Ivenix Inc. Secures $42 Million in Funding 3SHL Group Reaches Major Milestone of 3000 Employees 2
Cached News: